Skip to content
10-Q

Quarterly Report

Selectis Health, Inc. GBCS

0001493152-26-024987

← back to feed
Filed
May 22, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 20, 2026 3.07M sh
Shares Diluted Q1 2026 · Mar 31, 2026 3.44M sh
Shares Diluted Q1 2026 · Mar 31, 2025 3.07M sh
Capex Q1 2026 · Mar 31, 2026 $377.2K
Capex Q1 2026 · Mar 31, 2025 $219.24K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$2.29M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $1.04M
Long Term Debt Q1 2026 · Mar 31, 2026 $13.33M
Long Term Debt Q1 2026 · Dec 31, 2025 $13.41M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $1.29M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $1.01M
Stockholders Equity Q1 2026 · Mar 31, 2026 $258.34K
Stockholders Equity Q1 2026 · Dec 31, 2025 −$6.21M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$6.08M
Stockholders Equity Q1 2026 · Dec 31, 2024 −$5.41M
Current Liabilities Q1 2026 · Mar 31, 2026 $16.32M
Current Liabilities Q1 2026 · Dec 31, 2025 $25.27M
Total Liabilities Q1 2026 · Mar 31, 2026 $29.75M
Total Liabilities Q1 2026 · Dec 31, 2025 $38.79M
Current Assets Q1 2026 · Mar 31, 2026 $9.82M
Current Assets Q1 2026 · Dec 31, 2025 $7.58M
Total Assets Q1 2026 · Mar 31, 2026 $30.01M
Total Assets Q1 2026 · Dec 31, 2025 $32.58M
Eps Diluted Q1 2026 · Mar 31, 2026 $1.90
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.22
Eps Basic Q1 2026 · Mar 31, 2026 $2.13
Eps Basic Q1 2026 · Mar 31, 2025 −$0.22
Sga Expense Q1 2026 · Mar 31, 2026 $2.13M
Sga Expense Q1 2026 · Mar 31, 2025 $2.37M
Net Income Q1 2026 · Mar 31, 2026 $6.53M
Net Income Q1 2026 · Mar 31, 2025 −$655.97K
Operating Income Q1 2026 · Mar 31, 2026 −$1.26M
Operating Income Q1 2026 · Mar 31, 2025 −$421.75K
Revenue Q1 2026 · Mar 31, 2026 $7.29M
Revenue Q1 2026 · Mar 31, 2025 $10.49M
Short Term Debt Q1 2026 · Dec 31, 2025 $775K